Reaction Details Report a problem with these data
Target
Alpha-1D adrenergic receptor
Ligand
BDBM50213516
Substrate
n/a
Meas. Tech.
ChEMBL_438894 (CHEMBL889237)
Ki
3±n/a nM
Citation
 Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorg Med Chem Lett 17:3930-4 (2007) [PubMed]  Article 
Target
Name:
Alpha-1D adrenergic receptor
Synonyms:
ADA1D_HUMAN | ADRA1A | ADRA1D | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1D-adrenoceptor | Alpha 1D-adrenoreceptor | Alpha adrenergic receptor (1a and 1d) | Alpha-1D adrenoceptor | Alpha-adrenergic receptor 1a | adrenergic Alpha1D
Type:
Enzyme Catalytic Domain
Mol. Mass.:
60485.82
Organism:
Homo sapiens (Human)
Description:
adrenergic Alpha1D ADRA1D HUMAN::P25100
Residue:
572
Sequence:
MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI
  
Inhibitor
Name:
BDBM50213516
Synonyms:
CHEMBL439197 | N-((1s,4s)-4-(4-(2-(2,2,2-trifluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide
Type:
Small organic molecule
Emp. Form.:
C27H33F3N2O5S
Mol. Mass.:
554.622
SMILES:
FC(F)(F)COc1ccccc1C1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1ccc2OCCOc2c1 |wU:18.19,21.26,(-5.05,-19.16,;-5.81,-20.51,;-4.47,-21.27,;-7.15,-19.75,;-6.58,-21.84,;-5.8,-23.18,;-6.58,-24.52,;-8.1,-24.52,;-8.89,-25.84,;-8.12,-27.19,;-6.58,-27.19,;-5.8,-25.85,;-4.25,-25.85,;-3.48,-27.2,;-1.95,-27.2,;-1.18,-25.87,;-1.94,-24.55,;-3.48,-24.52,;.39,-25.87,;1.16,-27.22,;2.68,-27.22,;3.44,-25.9,;2.68,-24.59,;1.15,-24.55,;5.02,-25.9,;5.77,-24.6,;4.45,-23.83,;7.13,-25.37,;6.54,-23.25,;5.78,-21.93,;6.55,-20.58,;8.11,-20.58,;8.89,-19.25,;10.43,-19.26,;11.19,-20.6,;10.41,-21.93,;8.86,-21.93,;8.1,-23.25,)|
Structure:
Search PDB for entries with ligand similarity: